Cellectar Biosciences, Inc. (CLRB) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Cellectar Biosciences, Inc. (CLRB) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

CLRB Income Statement

Cellectar Biosciences, Inc. (CLRB) annual income statement — 22-year revenue, gross profit & net income history

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Sales/Revenue	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Revenue Growth %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Goods Sold	0	-110.02K	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
COGS % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	110.02K	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Gross Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	7.2M	5.9M	5.69M	4.85M	6.04M	6.4M	12.74M	13.33M	13.7M	12M	12.55M	9.41M	8.29M	8.71M	7.42M	7.82M	7.44M	6.14M	5.92M	5.82M
OpEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Selling, General & Admin	2.64M	2.9M	2.53M	2.33M	3.65M	2.97M	6.54M	7.83M	6.36M	4.91M	4.61M	2.38M	2.16M	2.35M	1.97M	2.44M	2.94M	2.25M	1.54M	1.88M
SG&A % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Research & Development	4.56M	3.01M	3.16M	2.52M	2.39M	3.43M	6.21M	5.49M	7.35M	7.09M	7.94M	7.03M	6.14M	6.36M	5.45M	5.38M	4.5M	3.89M	4.39M	3.94M
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Operating Income	-7.2M	-5.79M	-5.69M	-4.85M	-6.04M	-6.4M	-12.74M	-13.33M	-13.7M	-12M	-12.55M	-9.41M	-8.29M	-8.71M	-7.42M	-7.82M	-7.44M	-6.14M	-5.92M	-5.82M
Operating Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income Growth %	-19.19%	9.48%	55.35%	63.6%	55.94%	46.66%	-1.57%	-41.58%	-65.22%	-37.86%	-69.05%	-20.45%	-11.55%	-41.77%	-25.31%	-34.29%	-23.34%	3.45%	-55.9%	-48.84%
EBITDA	-6.93M	-5.9M	-5.64M	-4.8M	-5.98M	-6.34M	-12.68M	-13.26M	-13.64M	-11.91M	-12.48M	-9.37M	-8.26M	-8.66M	-7.38M	-7.78M	-7.4M	-6.1M	-5.88M	-5.78M
EBITDA Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA Growth %	-15.86%	6.95%	55.5%	63.81%	56.14%	46.74%	-1.59%	-41.47%	-65.2%	-37.52%	-68.98%	-20.43%	-11.53%	-42.09%	-25.5%	-34.58%	-23.57%	3.6%	-56.34%	-49.27%
D&A (Non-Cash Add-back)	0	-110.02K	49.46K	52.28K	55.56K	56.3K	68.57K	68.57K	66.02K	88.49K	69.96K	41.21K	38.65K	42.56K	38.16K	32.96K	33.9K	43.42K	39.29K	36.79K
EBIT	-6.93M	-5.65M	-5.3M	-4.44M	-5.45M	-6.6M	-2.29M	-14.66M	-919.37K	-26.64M	-12.55M	-9.41M	-8.29M	-8.71M	-7.42M	-7.82M	-7.44M	-6.14M	-5.92M	-5.82M
Net Interest Income	133.36K	63K	97.58K	112.54K	88.02K	136.96K	244.21K	317.89K	328.91K	319.85K	139.22K	51.11K	72.78K	124.03K	147.44K	4.16K	481	430	0	590
Interest Income	133.36K	63K	97.58K	112.54K	88.02K	136.96K	244.21K	317.89K	328.91K	319.85K	139.22K	51.11K	72.78K	124.03K	147.44K	4.16K	481	430	0	590
Interest Expense	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Income/Expense	265.36K	140K	395.41K	406.82K	589.62K	-203.04K	10.46M	-1.34M	12.78M	-14.64M	4.61M	-8.11M	-1.88M	1.51M	-5.04M	4.16K	481	430	5.31K	590
Pretax Income	-6.93M	-5.65M	-5.3M	-4.44M	-5.45M	-6.6M	-2.29M	-14.66M	-919.37K	-26.64M	-7.94M	-17.52M	-10.18M	-7.19M	-12.47M	-7.81M	-7.44M	-6.14M	-5.92M	-5.82M
Pretax Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income Tax	0	0	0	0	0	0	66K	0	0	0	-60K	0	0	0	-60K	0	0	0	0	0
Effective Tax Rate %	0%	0%	0%	0%	0%	0%	-2.88%	0%	0%	0%	0.76%	0%	0%	0%	0.48%	0%	0%	0%	0%	0%
Net Income	-6.93M	-5.65M	-5.3M	-4.44M	-5.45M	-6.6M	-2.36M	-14.66M	-919.37K	-26.64M	-7.88M	-17.52M	-10.18M	-7.19M	-12.41M	-7.81M	-7.44M	-6.14M	-5.92M	-5.82M
Net Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income Growth %	-27.22%	14.39%	-124.81%	69.7%	-492.57%	75.21%	70.11%	16.3%	90.97%	-270.52%	36.48%	-124.29%	-36.9%	-17.11%	-109.64%	-34.24%	-23.34%	3.42%	-63.71%	-48.84%
Net Income (Continuing)	-6.93M	-5.65M	-5.3M	-4.44M	-5.45M	-6.6M	-2.36M	-14.66M	-919.37K	-26.64M	-7.88M	-17.52M	-10.18M	-7.19M	-12.41M	-7.81M	-7.44M	-6.14M	-5.92M	-5.82M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	-0.57	-1.33	-1.25	-1.41	-3.39	-4.30	-1.68	-11.18	-5.43	-27.24	-12.17	-46.48	-27.12	-19.16	-40.00	-38.35	-36.51	-30.15	-29.06	-29.16
EPS Growth %	83.19%	69.07%	25.6%	87.39%	37.57%	84.21%	86.2%	75.94%	79.97%	-42.18%	69.56%	-21.19%	25.72%	36.46%	-37.64%	-31.52%	-6.51%	23.91%	-21.76%	34.55%
EPS (Basic)	-0.57	-1.33	-1.25	-1.41	-3.39	-4.30	-1.68	-11.18	-0.77	-27.24	-12.17	-46.48	-27.12	-19.16	-40.00	-38.35	-36.51	-30.15	-29.06	-29.16
Diluted Shares Outstanding	12.23M	4.24M	4.24M	3.16M	1.61M	1.54M	1.4M	1.31M	1.25M	978.22K	647.37K	376.96K	375.37K	375.37K	310.2K	203.67K	203.67K	203.67K	203.67K	199.56K
Basic Shares Outstanding	12.23M	4.24M	4.24M	3.16M	1.61M	1.54M	1.4M	1.31M	169K	978.22K	647.37K	376.96K	375.37K	375.37K	310.2K	203.67K	203.67K	203.67K	203.67K	199.56K
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-